Female infertility - Epidemiology Forecast - 2032

January 2022 | 60 pages | ID: F388DA87590AEN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Female infertility - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Female infertility epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Female infertility Understanding

The DelveInsight Female infertility epidemiology report gives a thorough understanding of the Female infertility by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Female infertility in the US, Europe, and Japan. The report covers the detailed information of the Female infertility epidemiology scenario in seven major countries (US, EU5, and Japan).

Female infertility Epidemiology Perspective by DelveInsight

The Female infertility epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Female infertility epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Female infertility epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Female infertility Detailed Epidemiology Segmentation

The Female infertility epidemiology covered in the report provides historical as well as forecasted Female infertility epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Female infertility report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Female infertility report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Female infertility Epidemiology Report and Model provide an overview of the global trends of Female infertility in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Female infertility in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Female infertility
• The report provides the segmentation of the Female infertility epidemiology

Report Highlights

• 11-year Forecast of Female infertility epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Female infertility
• Cases of Female infertility by Mutation Types
• Female infertility Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Female infertility?
• What are the key findings pertaining to the Female infertility epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Female infertility across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Female infertility?
• What are the currently available treatments of Female infertility?

Reasons to buy

The Female infertility Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Female infertility market
• Quantify patient populations in the global Female infertility market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Female infertility therapeutics in each of the markets covered
• Understand the magnitude of Female infertility population by its epidemiology
• The Female infertility Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF FEMALE INFERTILITY

3. FEMALE INFERTILITY: DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Female infertility Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Female infertility Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Female infertility Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Female infertility Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Female infertility Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Female infertility Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Female infertility Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Female infertility Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Female infertility Treatment and Management
6.2. Female infertility Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Female infertility Epidemiology in 7MM (2019-2032)
Table 2: Female infertility Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Female infertility Epidemiology in the United States (2019-2032)
Table 4: Female infertility Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Female infertility Epidemiology in Germany (2019-2032)
Table 6: Female infertility Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Female infertility Epidemiology in France (2019-2032)
Table 8: Female infertility Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Female infertility Epidemiology in Italy (2019-2032)
Table 10: Female infertility Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Female infertility Epidemiology in Spain (2019-2032)
Table 12: Female infertility Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Female infertility Epidemiology in the United Kingdom (2019-2032)
Table 14: Female infertility Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Female infertility Epidemiology in Japan (2019-2032)
Table 16: Female infertility Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Female infertility Epidemiology in 7MM (2019-2032)
Figure 2 Female infertility Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Female infertility Epidemiology in the United States (2019-2032)
Figure 4 Female infertility Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Female infertility Epidemiology in Germany (2019-2032)
Figure 6 Female infertility Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Female infertility Epidemiology in France (2019-2032)
Figure 8 Female infertility Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Female infertility Epidemiology in Italy (2019-2032)
Figure 10 Female infertility Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Female infertility Epidemiology in Spain (2019-2032)
Figure 12 Female infertility Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Female infertility Epidemiology in the United Kingdom (2019-2032)
Figure 14 Female infertility Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Female infertility Epidemiology in Japan (2019-2032)
Figure 16 Female infertility Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report